BOSTON and GREENWOOD, S.C., March 19, 2013 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for its BENCHlab NGS and CNV solutions with South Carolina-based Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory testing.
Cartagenia's NGS product is tailored to support the adoption of Next Generation Sequencing technology in clinical practice and focuses on standardizing the data interpretation process. The NGS product was created to handle such data as gene panels, exomes and whole genomes and to automatically generate clinical reports specific to Greenwood's needs.
After developing the product and using it extensively in Europe, Greenwood is the first US customer to license the NGS product.
The Cartagenia BENCHlab CNV solution is a product that helps labs deploy microarray testing for prenatal diagnosis, as well as a seamless transition from prenatal to continued post-natal follow-up.
"We generate DNA sequencing data on large portions of the genome and Cartagenia's products facilitate the sorting, filtering and organization of these data and ultimately aid in the process of interpreting the genetic alterations," said Mike Friez , Greenwood's Director of Diagnostic Laboratories, adding that while most of Greenwood's clinical samples originate in South Carolina, they also receive samples from around the country and even internationally. "The amount of raw information produced by these types of tests creates a com
Copyright©2012 PR Newswire.
All rights reserved